India to begin trials for Ayurvedic drugs to fight COVID-19
The AYUSH Ministry is working to validate four Ayurvedic medicine formulations against COVID-19 along with Council of Scientific and Industrial Research (CSIR). The trials will begin within a week. These formulations will be tried as an add-on therapy and standard care for COVID-19 patients.
Union Minister of State for AYUSH Shripad Y Naik revealed this matter on Twitter. He hoped Ayurveda would show positive results to overcome this pandemic.
CSIR Director-General Shekhar Mande and AYUSH secretary Vaidya Rajesh Kotecha said that result will come within three months once the clinical trials begin.
CSIR Director-General Shekhar Mande said that Ayurveda principles existed long before and it is vital to validate at least some of them. It is the right time to validate Ayurvedic formulations to fight against coronavirus pandemic.
The AYUSH secretary said that four Ayurvedic formulations, Ashwagandha, Yashtimadhu (Mulethi), Guduchi and Pippali (Giloy) are going to be tested against COVID-19.
He added that repurposing of the malarial drug, AYUSH-64 will be done. He added that two stimulus studies are planned on the high-risk population for Ashwagandha. A competitive study has been planned between Hydroxychloroquine and Ashwagandha.
This clinical study will be conducted in various parts of the country with variable design. A task force has been formed to prepare guidelines for a clinical trial.
Many scientists across the country from the medical field from CSIR and other institutions have reviewed it. The advice of ICMR has also been taken in this regard.
They identified the centres and investigators and finalized all things for the clinical trial. AYUSH also approved to start the trial.
Standard drugs have been procured as per the standard size requirements. They are planning to begin the trials in the next week.
Image Credit: Image by Pradeep Kumar from Pixabay (Free for commercial use)
Image Reference: https://pixabay.com/photos/ayurvedic-herbal-alternative-756352/
Recent Posts
- Lalitha Dolls: Innovation rooted in traditionBeyond just toys, Lalitha dolls symbolize a unique cultural narrative, appealing to audiences both in India and abroad.
- Pinaka MBRL, a game-changer in India’s ArtilleryThe Indian Army plans to deploy the Pinaka system later this year, a move that will significantly enhance its artillery firepower.
- Chachi Ki Rasoi is a lifeline for Sonbhadra tribal villagesChachi Ki Rasoi now feeds 80-100 people daily, operating 20-25 days a month.
- Lalitha Dolls: Innovation rooted in tradition
What’s new at WeRIndia.com
News from 700+ sources
-
Q3 Results Today Live: Adani Green Energy, Hindustan Petroleum, Ultratech, Zee Entertainment, Mphasis, Nippon to announce Q3 results.
-
Stock Recommendations Today: HUL, HDFC Bank, BPCL, Persistent Systems On Brokerages’ Radar
-
Saif Ali Khan Attacked News LIVE: Actor Gets Security By Mumbai Police; Attacker’s ‘Hindi With Heavy Bangladeshi Accent’ Creates Trouble
-
Report reveals Elon Musk wanted Ramaswamy out of DOGE
-
Coforge Q3 Result: Net Profit Misses Estimate, Third Interim Dividend Announced
-
Is Mr Beast buying TikTok? Who is he and what we know so far
-
WeRIndia – A News Aggregator
Visit werindia.com for all types of National | Business | World | Politics | Entertainment | Health related news and much more..
Leave a Reply